<SEC-DOCUMENT>0001021561-15-000071.txt : 20151006
<SEC-HEADER>0001021561-15-000071.hdr.sgml : 20151006
<ACCEPTANCE-DATETIME>20151006163649
ACCESSION NUMBER:		0001021561-15-000071
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20150930
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20151006
DATE AS OF CHANGE:		20151006

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NU SKIN ENTERPRISES INC
		CENTRAL INDEX KEY:			0001021561
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122]
		IRS NUMBER:				870565309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12421
		FILM NUMBER:		151146415

	BUSINESS ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: CLAYTON JONES
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601
		BUSINESS PHONE:		801-345-1000

	MAIL ADDRESS:	
		STREET 1:		75 WEST CENTER ST
		STREET 2:		ATTN: CLAYTON JONES
		CITY:			PROVO
		STATE:			UT
		ZIP:			84601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NU SKIN ASIA PACIFIC INC
		DATE OF NAME CHANGE:	19960919
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>preearn10062015.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: j
    Document created using EDGARfilings PROfile 3.5.0.0
    Copyright 1995 - 2015 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">UNITED STATES</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">SECURITIES AND EXCHANGE COMMISSION</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Washington, D.C. 20549</div>

<div><br>
</div>

<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">FORM 8-K</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">CURRENT REPORT</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

<div><br>
</div>

<table id="7147c53495b347498a6ea47f88cf5b3e" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%; BORDER-COLLAPSE: collapse" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">October 6, 2015</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">Date of Report (Date of earliest event reported)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">NU SKIN ENTERPRISES, INC.</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(Exact name of registrant as specified in its charter)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Delaware</div>
</td>
<td style="WIDTH: 12.92%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 26.55%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">001-12421</div>
</td>
<td style="WIDTH: 13.63%; VERTICAL-ALIGN: bottom">&#160;</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">87-0565309</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(State or other jurisdiction of incorporation)</div>
</td>
<td style="WIDTH: 12.92%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 26.55%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(Commission File Number)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 13.63%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(IRS Employer Identification Number)</div>
</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: middle; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">75 West Center Street</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">Provo, Utah 84601</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(Address of principal executive offices and zip code)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">(801) 345-1000</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(Registrant's telephone number, including area code)</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: bottom; BORDER-BOTTOM: #000000 2px solid" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">N/A</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">&#160;</td>
</tr>

<tr>
<td style="WIDTH: 23.36%; VERTICAL-ALIGN: top">&#160;</td>
<td style="WIDTH: 53.1%; VERTICAL-ALIGN: top" colspan="3">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: center">(Former name or former address, if changed since last report)</div>

<div>&#160;</div>
</td>
<td style="WIDTH: 23.54%; VERTICAL-ALIGN: top">&#160;</td>
</tr>
</table>

<div><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9633;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 6pt">&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left"><font style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif">&#9633;</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 6pt">&#160;&#160;&#160;&#160;&#160; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left">
<table id="6fd9d2309a794bfeb63fc29576120b1d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 18pt; VERTICAL-ALIGN: top; align: right">&#9633;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left">
<table id="8acbe395416144dca023fca1c11e4ec0" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 14pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 18pt; VERTICAL-ALIGN: top; align: right">&#9633;</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4 (c))</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 12pt"><br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Item 2.02</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 5.14pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Results of Operations and Financial Condition.</font></div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">On October 6, 2015, Nu Skin Enterprises, Inc. (the "Company") issued a press release updating its revenue guidance for the third quarter ended September 30, 2015.&#160; A copy of the Company's press release is attached as Exhibit 99.1 to this report and incorporated by reference.</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">The information furnished pursuant to this Item 2.02 and the exhibit hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such filing.</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">The press release furnished herewith in Exhibit 99.1 may contain non-GAAP financial measures. Management believes non-GAAP financial measures assist management and investors in evaluating and comparing period-to-period results and projections in a more meaningful and consistent manner.</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left">
<table id="8d5633a72bc540658c8fc3a04b26e12d" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 108pt; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; align: right">Item 9.01</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; FONT-WEIGHT: bold; TEXT-ALIGN: left">Financial Statements and Exhibits.</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">(d)</font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 5.14pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">Exhibit.</font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left">
<table id="e6727a30327d43c0beeb2231017c2da3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 72pt; VERTICAL-ALIGN: top; align: right">99.1</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">Nu Skin Enterprises' press release dated October 6, 2015, regarding the third quarter ended September 30, 2015.</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left; MARGIN-LEFT: 108pt; TEXT-INDENT: -108pt"><br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">SIGNATURE</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 216pt"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">NU SKIN ENTERPRISES, INC.</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> (Registrant)</div>

<div><br>
</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-VARIANT: normal; FONT-WEIGHT: normal; FONT-STYLE: normal; TEXT-ALIGN: left; MARGIN-LEFT: 216pt"><u>/s/ Ritch Wood</u></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left; MARGIN-LEFT: 216pt">Ritch Wood<font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font> Chief Financial Officer</div>

<div><br>
</div>

<div><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">Date:&#160; October 6, 2015</div>

<div style="MARGIN-BOTTOM: 12pt"><br>
</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; TEXT-ALIGN: center">EXHIBIT INDEX</div>

<div style="MARGIN-BOTTOM: 12pt"><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><u>Exhibit No.</u></font><font id="TRGRRTFtoHTMLTab" style="FONT-SIZE: 5.02pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold"><u>Exhibit Description</u></font></div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left">
<table id="974a06e8d5c64c7e938031c080ff5368" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt"></td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 72pt; VERTICAL-ALIGN: top; align: right">99.1</td>
<td style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: auto; VERTICAL-ALIGN: top; TEXT-ALIGN: left">Nu Skin Enterprises' press release dated October 6, 2015, regarding&#160;the third quarter ended September 30, 2015.</td>
</tr>
</table>
</div>

<div style="MARGIN-BOTTOM: 12pt"><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; TEXT-ALIGN: left; MARGIN-LEFT: 216pt; TEXT-INDENT: -216pt"><br>
</div>

<div style="MARGIN-BOTTOM: 12pt"><br>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>PRESS RELEASE Q3 2015
<TEXT>
<html>
<head>
<title></title>
<!--Licensed to: j
    Document created using EDGARfilings PROfile 3.5.0.0
    Copyright 1995 - 2015 Summit Financial Printing, LLC.  All rights reserved.-->
</head>
<body style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif" bgcolor="#ffffff" text="#000000">
<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left"><img src="image00001.jpg"></div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">FOR IMMEDIATE RELEASE</div>

<div>
<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: left">CONTACTS:</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">Investors </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">&#8212; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">Scott Pond (801) 345-2657, </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #0063ff"><u>spond@nuskin.com</u></font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif"><br>
</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">Media </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">&#8212; </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">Kara Schneck (801) 345-2116, </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #0063ff"><u>kschneck@nuskin.com</u></font></div>
</div>

<div><br>
</div>

<div>
<div style="MARGIN-BOTTOM: 12pt"><br>
</div>

<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">NU SKIN ENTERPRISES UPDATES REVENUE GUIDANCE </div>

<div style="FONT-WEIGHT: bold"><br>
</div>
</div>

<div>
<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold; COLOR: #000000; TEXT-ALIGN: center">FOR THIRD-QUARTER 2015</div>

<div><br>
</div>
</div>

<div>
<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">PROVO, Utah &#8212; Oct. 6, 2015 &#8212; Nu Skin Enterprises, Inc. (NYSE: NUS) today updated its revenue guidance for the third quarter of 2015 in advance of this week's global sales leader convention. The company estimates third-quarter revenue in a range of $570 to $573 million, approximately even with the prior year on a constant-currency basis. Foreign currency headwinds associated with the strengthening of the U.S. dollar negatively impacted revenue by more than $60 million compared to the prior-year period. The revised revenue range is expected to represent continued improvement on a sequential basis, and the company continues to forecast constant-currency revenue growth in the fourth quarter of 2015 versus the prior year.</div>

<div><br>
</div>
</div>

<div>
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">"As we look at our global business, we have seen improving revenue trends each quarter throughout 2015 and expect to be even with prior-year revenue on a constant-currency basis in the third quarter," said Truman Hunt, president and chief executive officer. "Our third-quarter results will be in line with expectations, with the exception of the Greater China region. Revenue growth in the third quarter was particularly strong in South Asia/Pacific, where our first introduction of ageLOC Youth drove more than 20 percent growth in that region, or more than 40 percent on a constant-currency basis.</div>

<div>&#160;</div>

<div>&#160;</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: center">-more-</div>

<div>&#160;</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div>Nu Skin Enterprises, Inc.</div>

<div>Oct. 6, 2015</div>

<div>Page 2</div>

<div><br>
 &#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">"Third-quarter results were impacted by lower-than-expected sales of our new cosmetic oils in China during August and September, which may be a reflection of economic conditions in China," continued Hunt.</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left">"Given the successful launch of ageLOC Youth in South Asia/Pacific, we look forward to the introduction of ageLOC Youth as well as ageLOC Me in most of our regions during the fourth quarter. We forecast year-over-year constant-currency revenue growth of between 7 and 10 percent in the fourth quarter," concluded Hunt.</div>

<div><br>
</div>
</div>

<div>
<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">The Nu Skin management team plans to release third quarter 2015 results after the market closes on Nov. 5, 2015 and will host a conference call with the investment community on Nov. 5, 2015, at 5 p.m. (EST) to discuss these results.</div>

<div><br>
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: left">About Nu Skin Enterprises, Inc.</div>

<div>
<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">Nu Skin Enterprises, Inc. demonstrates its tradition of innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. The company's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company. The company's anti-aging products feature the ageLOC</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"> line of products including ageLOC</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"> Tru Face</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"> Essence Ultra firming serum, the ageLOC</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"> TR90</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"> weight management and body shaping system, ageLOC</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"> R</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">2</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"> nutritional supplement, and ageLOC</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000"> Transformation daily skin care system. A global direct selling company, Nu Skin operates in 53 markets worldwide and is traded on the New York Stock Exchange under the symbol "NUS." More information is available at </font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif">http://www.nuskin.com</font><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000">.</font></div>

<div><br>
</div>
</div>

<div><br>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left"><font style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-WEIGHT: bold">Please Note:</font> This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws and include, but are not limited to, statements of management's expectations regarding the company's performance, growth and new product introductions; projections regarding revenue; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can identify these statements by forward-looking words such as "believe," "expect," "forecast," "project," "anticipate," "estimate," "intend," "plan," "targets," "likely," "will," "would," "could," "may," "might," the negative of these words and other similar words.</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">&#160;</div>

<div style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: normal; text-align: center;">-more-</div>

<div id="DSPFPageBreakArea" style="MARGIN-BOTTOM: 10pt; CLEAR: both; MARGIN-TOP: 10pt">
<div id="DSPFPageBreak" style="PAGE-BREAK-AFTER: always">
<hr style="BORDER-LEFT-WIDTH: 0px; HEIGHT: 2px; BORDER-RIGHT-WIDTH: 0px; WIDTH: 100%; BORDER-BOTTOM-WIDTH: 0px; COLOR: #000000; CLEAR: both; MARGIN: 4px 0px; BORDER-TOP-WIDTH: 0px; BACKGROUND-COLOR: #000000" noshade="noshade">
</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">
<div>Nu Skin Enterprises, Inc.</div>

<div>Oct. 6, 2015</div>

<div>Page 3</div>

<div>&#160;</div>

<div>&#160;</div>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:</div>

<div><br>
</div>

<div>
<table id="5efba57d94a94eae94022da5b98a49ae" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">estimates and guidance concerning anticipated revenue are preliminary estimates, and actual results may differ from the estimates and guidance provided;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="abea758939c64f8d88a9d68920a13018" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">any failure of current or planned initiatives or products to generate interest among our sales force and customers and generate sponsoring and selling activities on a sustained basis;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="aa0110b357db4adf80ca5cc7edc957cc" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">risk of foreign currency fluctuations and the currency translation impact on the company's business associated with these fluctuations;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="f1a0a5d3845141c0ac6fffe132337b54" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">risk that direct selling laws and regulations in any of our markets, including the United States and China, may be modified, interpreted or enforced in a manner that results in negative changes to our business model or negatively impacts our revenue, sales force or business, including through the interruption of sales activities, loss of licenses, imposition of fines, or any other adverse actions or events;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="1526218710d1438197ca5bcdcbf754b8" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">risks related to accurately predicting, delivering or maintaining sufficient quantities of products to support our planned initiatives or launch strategies, and increased risk of inventory write-offs if we over-forecast demand for a product or change our planned initiatives or launch strategies;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="9c36f3c2b70d4cd7a26f8c87ea6c31c2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">regulatory risks associated with the company's products, which could require the company to modify its claims or inhibit the company's ability to import or continue selling a product in a market if it is determined to be a medical device or if it is unable to register the product in a timely manner under applicable regulatory requirements;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="948beb208532495eb4b6a009dc2f3af7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">adverse publicity related to the company's business, products, industry or any legal actions or complaints by the company's sales force or others;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="2861865c8dea4e8582975aaa5aa6dbd2" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">unpredictable economic conditions and events globally;</div>
</td>
</tr>
</table>
</div>

<div>
<table id="9554486f177b49b98383c8b9695c6ad7" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">any prospective or retrospective increases in duties on the company's products imported into the company's markets outside of the United States and any adverse results of tax audits or unfavorable changes to tax laws in the company's various markets; and</div>
</td>
</tr>
</table>
</div>

<div>
<table id="fb2d5c285d614cf882cb1a7b2778a8e3" class="DSPFListTable" style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; WIDTH: 100%" cellspacing="0" cellpadding="0">
<tr>
<td style="WIDTH: 36pt; VERTICAL-ALIGN: top; align: right">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: Symbol, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left; MARGIN-LEFT: 18pt">&#183;</div>
</td>
<td style="WIDTH: auto; VERTICAL-ALIGN: top">
<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; FONT-STYLE: italic; TEXT-ALIGN: left">continued competitive pressures in the company's markets.</div>
</td>
</tr>
</table>
</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">&#160;</div>

<div style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; FONT-STYLE: italic; TEXT-ALIGN: left">The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided and the company assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.</div>

<div><br>
</div>

<div><br>
</div>

<div>
<div style="MARGIN-BOTTOM: 12pt; FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman', Times, serif; COLOR: #000000; TEXT-ALIGN: center"># # #</div>

<div><br>
</div>
</div>
</div>
</body>
</html>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" "1 -$# 2(  A$! Q$!_\0
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M%Y]6T!S'K6FKYR$C9,FWG:?4'!P?4?6F>*M7N_%7A+PGIMJ_ESZ^RBX=>RH
M9/PSS^&*O3:/;:1\4='OM)")9ZU;SQS1Q?<8JF_<,<8/!_#WK'\'D1?\()(
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MXH M3ZR(XY=MM*+F,IF"0A"59MH8'D$9]#3]+UB'4;B6&*.5'B&6WK@9W%<
M]^F?H11;6=U_: N[N2!GV>5L12 JYSQD\DG'Y5I  = !0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
'!1110!__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
